Synaptic Medical Appoints Robert Ricker as Vice President of US Commercialization

LAKE FOREST, Calif., October 24, 2019 – Synaptic Medical, a medical device company that focuses on developing breakthrough products for the treatment of arrhythmias and other cardiovascular diseases, today announced that Robert C. Ricker has been appointed Vice President of US Commercialization. Mr. Ricker’s broad executive experience in the cardiovascular industry are invaluable to the future success of Synaptic.

Sophia Wang, CEO of Synaptic, said that she and her colleagues are excited to bring Robert on board, noting that his cardiovascular expertise and understanding of the cardiovascular market will be invaluable for the company’s future growth. “We are pleased to welcome Mr. Ricker to Synaptic as part of our commitment to treating cardiovascular disease in the US”

Robert Ricker most recently served as senior vice president for Asahi Intecc. In this role, Mr. Ricker’s responsibilities included founding and leading all commercial functions, and commercial performance of the coronary, peripheral, and neurovascular segments. Prior to that, Mr. Ricker had roles of increasing responsibility within Asahi Intecc as well as positions with Abbott Vascular.

Robert received a bachelor’s degree in Marketing from Salisbury State University in Maryland, and an MBA from the University of Southern California.

About Synaptic Medical
Synaptic Medical is a medical device company focused on developing and commercializing breakthrough products for the treatment of cardiac arrhythmias and other cardiovascular diseases. Our mission is to develop unique, cost-effective, and clinically advanced technologies with the highest quality to enable physicians to optimize and expand treatment options. The company was founded in 2005 in Minnesota. Learn more at

The search was handled by Paula Rutledge and Joy Celebre of Legacy MedSearch, named to Forbes 2019 Americas Best Executive Recruiting Firms.

Share This Article